Monograph on the Potential Human Reproductive and ... - OEHHA
Monograph on the Potential Human Reproductive and ... - OEHHA
Monograph on the Potential Human Reproductive and ... - OEHHA
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
224<br />
Table 57<br />
In Vitro Genetic Toxicity Studies of Bisphenol A<br />
C<strong>on</strong>centrati<strong>on</strong> Cell Endpoint Results Reference<br />
Haworth et al. (1983) a,b<br />
Negative<br />
Schweikl et al. (1998) a,b<br />
Negative<br />
Takahata et al. (1990) a,b<br />
Negative<br />
Dean <strong>and</strong> Brooks<br />
(1978) a,b<br />
Negative<br />
JETOC (1996) a,b<br />
Masuda et al. (2005)<br />
Salm<strong>on</strong>ella typhimurium strains TA98, TA100, Mutagenicity<br />
TA1535, TA1537<br />
Salm<strong>on</strong>ella typhimurium strains TA97a, TA98, Mutagenicity<br />
TA100, TA102<br />
Salm<strong>on</strong>ella typhimurium strains TA97, TA98, Mutagenicity<br />
TA100, TA102<br />
Salm<strong>on</strong>ella typhimurium strain TA1538 <strong>and</strong> Mutagenicity<br />
Escherichia coli strains<br />
WP2 <strong>and</strong> WP2uvrA<br />
Salm<strong>on</strong>ella typhimurium strains TA98, TA100, Mutagenicity<br />
TA1535, TA1537,<br />
<strong>and</strong> Escherichia coli strain WP2uvrA<br />
Salm<strong>on</strong>ella typhimurium strains TA98 <strong>and</strong> TA100 Mutagenicity<br />
3.3–333.3 mg/plate, with <strong>and</strong> without metabolic<br />
activati<strong>on</strong><br />
50–500 mg/plate, with <strong>and</strong> without metabolic<br />
activati<strong>on</strong><br />
r5000 mg/plate with <strong>and</strong> without metabolic<br />
activati<strong>on</strong><br />
r1000 mg/mL, with <strong>and</strong> without metabolic<br />
activati<strong>on</strong><br />
Negative<br />
5–1250 mg/plate, with <strong>and</strong> without metabolic<br />
activati<strong>on</strong><br />
Negative<br />
Schweikl et al. (1998) a,b<br />
Negative<br />
Chinese hamster V79 cells, hprt locus Mutagenicity<br />
Myhr <strong>and</strong> Caspary<br />
(1991) a,b<br />
Negative (results questi<strong>on</strong>ed due to<br />
possible inability to count small<br />
col<strong>on</strong>ies)<br />
Mouse lymphoma L5178Y cells, tk 1/- locus Mutagenicity<br />
CHAPIN ET AL.<br />
H<strong>on</strong>ma et al. (1999) a,b ;<br />
Moore et al. (1999) a,b<br />
Tsutsui et al. (1998) a,b<br />
Inc<strong>on</strong>clusive without <strong>and</strong> negative with<br />
metabolic activati<strong>on</strong><br />
Negative<br />
Mouse lymphoma L5178Y cells, tk 1/- locus Mutagenicity<br />
Takahashi et al. (2001)<br />
m at all doses<br />
Syrian hamster embryo cells (Na1/K1 ATPase Mutagenicity<br />
<strong>and</strong> hprt loci)<br />
<strong>Human</strong> RSa cells Mutagenicity<br />
Dean <strong>and</strong> Brooks<br />
(1978) a,b<br />
Iso et al. (2006)<br />
Negative<br />
Saccharomyces cerevisiae strain JDI Mutagenicity<br />
m at Z10 -6 M [0.2 mg/L]<br />
1mM [228 mg/L], with <strong>and</strong> without metabolic<br />
activati<strong>on</strong><br />
0.1–0.2 mM [23–46 mg/L], without metabolic<br />
activati<strong>on</strong><br />
5–60 mg/L without metabolic activati<strong>on</strong>, 25–<br />
200 mg/L<br />
with metabolic activati<strong>on</strong>, or 5–60 mg/L with<br />
<strong>and</strong><br />
without metabolic activati<strong>on</strong> d<br />
C<strong>on</strong>centrati<strong>on</strong>s not specified, with <strong>and</strong> without<br />
metabolic activati<strong>on</strong><br />
25–200 mM [5.7–46 mg/L], without metabolic<br />
activati<strong>on</strong><br />
10 -8 –10 -5 M [0.002–2 mg/L], without metabolic<br />
activati<strong>on</strong><br />
r500 mg/L, with <strong>and</strong> without metabolic<br />
activati<strong>on</strong><br />
10 –8 –10 -4 M [0.002–23 mg/L], without metabolic<br />
activati<strong>on</strong><br />
10 -4 M[23 mg/L], without metabolic activati<strong>on</strong><br />
m<br />
MCF-7 cells DNA damage (assessed<br />
by comet assay)<br />
MDA-MB-231 cells DNA damage (assessed<br />
by comet assay)<br />
Chinese hamster ovary (CHO) cells Chromosomal<br />
aberrati<strong>on</strong><br />
Ivett et al. (1989) a,b ;<br />
Tennant et al. (1986,<br />
1987) b<br />
Hilliard et al. (1998) a<br />
Negative (inc<strong>on</strong>sistent m at high dose<br />
with metabolic activati<strong>on</strong>)<br />
Positive at Z400 mM [91.3 mg/L]<br />
without metabolic activati<strong>on</strong> c ;<br />
negative with metabolic activati<strong>on</strong><br />
CHO cells, cl<strong>on</strong>e WBL Chromosomal<br />
aberrati<strong>on</strong><br />
Galloway et al. (1998) a<br />
Positive c<br />
Tsutsui et al. (1998) a,b<br />
Negative<br />
Dean <strong>and</strong> Brooks<br />
(1978) b<br />
Tsutsui et al. (1998) a,b<br />
Negative<br />
CHO cells, cl<strong>on</strong>e WBL Chromosomal<br />
aberrati<strong>on</strong><br />
Syrian hamster embryo cells Chromosomal<br />
aberrati<strong>on</strong><br />
Epi<strong>the</strong>lial-type rat liver cell line (RL1) Chromosomal<br />
aberrati<strong>on</strong><br />
Syrian hamster embryo cells Aneuploidy/<br />
polyploidy<br />
20–40 mg/L, without metabolic activati<strong>on</strong> <strong>and</strong><br />
30–50 mg/L<br />
with metabolic activati<strong>on</strong><br />
350–450 mM [80–103 mg/L], without metabolic<br />
activati<strong>on</strong><br />
<strong>and</strong> r250 mM [57 mg/L] with metabolic<br />
activati<strong>on</strong><br />
400 <strong>and</strong> 450 mM [91 <strong>and</strong> 103 mg/L], without<br />
metabolic activati<strong>on</strong><br />
25–200 mM [5.7–46 mg/L], without metabolic<br />
activati<strong>on</strong><br />
10–30 mg/L<br />
25–200 mM [5.7–46 mg/L], without metabolic<br />
activati<strong>on</strong><br />
Birth Defects Research (Part B) 83:157–395, 2008